ConductScience.org, home

Paper455263

5-fluorouracil, adriamycin, and mitomycin-C (FAM) combination chemotherapy in the treatment of advanced gastric cancer.

MacDonald JS and 5 others. Cancer, 1979. Cited by 129 papers, by iCite.

Cite this record

ConductScience Library. 5-fluorouracil, adriamycin, and mitomycin-C (FAM) combination chemotherapy in the treatment of advanced gastric cancer. Papers, record 455263. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/455263

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
5-fluorouracil, adriamycin, and mitomycin-C (FAM) combination chemotherapy in the treatment of advanced gastric cancer.
PubMed
Journal
Cancer
PubMed
Year
1979
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
129
iCite
Relative citation ratio, by iCite
6.21
iCite
Revised in PubMed
2019-06-19
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1MacDonald JSJ S
2Woolley PVP V
3Smythe TT
4Ueno WW
5Hoth DD
6Schein PSP S

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenocarcinomaMajor topic
DoxorubicinMajor topic
FluorouracilMajor topic
MitomycinsMajor topic
Stomach NeoplasmsMajor topic
Aged
Bone Marrow
Drug Therapy, Combination
Female
Humans
Male
Middle Aged
Prognosis
Remission, Spontaneous
Time Factors

Source PubMed

Download CSV of topics

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 129 citations.

PMIDTitleJournalYearIn PapersSource
19343158Evolution of preoperative and postoperative therapies in the management of localized gastroesophageal cancers.Gastrointest Cancer Res2007https://conductscience.org/library/papers/19343158PubMed
17353926Oxaliplatin, 5-fluorouracil/leucovorin and epirubicin as first-line treatment in advanced gastric carcinoma: a phase II study.Br J Cancer2007https://conductscience.org/library/papers/17353926PubMed
14676810Combination chemotherapy in advanced gastrointestinal cancers: ex vivo sensitivity to gemcitabine and mitomycin C.Br J Cancer2003https://conductscience.org/library/papers/14676810PubMed
9725015Derivatization of 5-fluorouracil with 4-bromomethyl-7-methoxycoumarin for determination by liquid chromatography-mass spectrometry.J Am Soc Mass Spectrom1998https://conductscience.org/library/papers/9725015PubMed
9654592Chemotherapy of oesophago-gastric cancer.Pathol Oncol Res1998https://conductscience.org/library/papers/9654592PubMed
7846911Significant prognostic factors by multivariate analysis of 3926 gastric cancer patients.World J Surg1994https://conductscience.org/library/papers/7846911PubMed
7687933Advanced breast cancer treatment with folinic acid, 5-fluorouracil, and mitomycin C.Cancer Chemother Pharmacol1993https://conductscience.org/library/papers/7687933PubMed
7676702Review of adjuvant chemotherapy for gastric cancer.World J Surg1995https://conductscience.org/library/papers/7676702PubMed
7248155Transition from laboratory to clinic in cancer treatment. Abstracts of symposium papers.Br J Cancer1981https://conductscience.org/library/papers/7248155PubMed
6925983A follow-up study on chemoimmunotherapy (5-fluorouracil and BCG) in advanced gastric cancer.Cancer Immunol Immunother1982https://conductscience.org/library/papers/6925983PubMed
6897785[Chemotherapy of gastric carcinoma].Langenbecks Arch Chir1982https://conductscience.org/library/papers/6897785PubMed
6897021Treatment of advanced gastric carcinoma with 5-fluorouracil adriamycin, and mitomycin C (FAM).Cancer Chemother Pharmacol1982https://conductscience.org/library/papers/6897021PubMed
6793759Late results of postoperative long term cancer chemotherapy for advanced carcinoma of the stomach.Jpn J Surg1981https://conductscience.org/library/papers/6793759PubMed
6668775Combination chemotherapy enhances survival of patients with unresectable gastric cancer.Jpn J Surg1983https://conductscience.org/library/papers/6668775PubMed
6406513
Chemotherapeutic study on Yoshida sarcoma ascites cells implanted into the glandular stomach of rats. Monotherapy with 5-fluorouracil, methyl-CCNU, mitomycin C, adriamycin, and cytosine arabinoside, and combination therapy with respective two-drug combinations.
J Cancer Res Clin Oncol1983https://conductscience.org/library/papers/6406513PubMed
3154829Clonogenic assay of gastric adenocarcinoma stem cells--clonogenic assay, stomach cancer.Korean J Intern Med1987https://conductscience.org/library/papers/3154829PubMed
3066394Gastric cancer--the recognition of a chemosensitive tumour.Br J Cancer1988https://conductscience.org/library/papers/3066394PubMed
2514857Cytotoxic drugs for gastric and colorectal cancer.BMJ1989https://conductscience.org/library/papers/2514857PubMed
1911206A less toxic regimen of 5-fluorouracil and high-dose folinic acid for advanced gastrointestinal adenocarcinomas.Br J Cancer1991https://conductscience.org/library/papers/1911206PubMed
1905707A cooperative randomized study on tegafur plus mitomycin C versus combined tegafur and uracil plus mitomycin C in the treatment of advanced gastric cancer.Jpn J Cancer Res1991https://conductscience.org/library/papers/1905707PubMed

See all 22 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/455263

GET https://conductscience.org/api/papers/v1/455263/cited_by?page=2